Tesevatinib in NSCLC Patients with EGFR Activating Mutations and Brain Metastases (BM) or Leptomeningeal Metastases (LM)

Berz, D; Subrananiam, D; Tonra, J; Berger, M; Camidge, DR

JOURNAL OF THORACIC ONCOLOGY, 2017; 12 (1): S942

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索